Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Merck
McKesson
Mallinckrodt
Moodys

Last Updated: December 2, 2021

DrugPatentWatch Database Preview

CHLORPROMAZINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Chlorpromazine Hydrochloride, and what generic alternatives are available?

Chlorpromazine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Genus, Pharm Assoc, Wockhardt, Abraxis Pharm, Dr Reddys, Eugia Pharma, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Cycle Pharms Ltd, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Lederle, Mayne Pharma, Purepac Pharm, Pvt Form, Sandoz, Sun Pharm, Upsher Smith Labs, Vangard, West Ward, Zydus, and Hikma Pharms. and is included in sixty-two NDAs.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.

Drug patent expirations by year for CHLORPROMAZINE HYDROCHLORIDE
Recent Clinical Trials for CHLORPROMAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Noha Mahmoud Nasreldin HassanPhase 2/Phase 3
Cairo UniversityPhase 2/Phase 3
Centre Hospitalier St AnnePhase 3

See all CHLORPROMAZINE HYDROCHLORIDE clinical trials

Pharmacology for CHLORPROMAZINE HYDROCHLORIDE
Drug ClassPhenothiazine

US Patents and Regulatory Information for CHLORPROMAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 080439-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Zydus CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 213368-005 Jan 17, 2020 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Kv Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 085750-002 Jan 4, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Glenmark Pharms Ltd CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 212144-002 Mar 23, 2021 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKesson
Dow
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.